A booster dose of Johnson & Johnson’s COVID-19 vaccine sharply increased levels of antibodies, according to interim data from two early-stage trials, the company said on Wednesday. A second dose…

Read more »

The post J&J Says Booster Dose Increased Antibodies in Early-Stage Studies appeared first on Hamodia.

In related news:

  1. Chicago Health Officials Using Antibody Testing to Determine if Someone Had the Virus
  2. With 2 Vaccines on the Horizon, Here’s What You Need to Know
  3. Moderna Confident Its Vaccine Works Against Variant Strains
  4. Some J&J Vaccine Doses Can Be Used, But Many Must Be Tossed
  5. EU Begins Real-Time Review of Sanofi-GSK COVID-19 Vaccine